CareFusion (NYSE:CFN)

CAPS Rating: 5 out of 5

The company offers clinical and medical products for infusion, surgical procedures, medical diagnostics, medication and supply dispensing, infection prevention, and respiratory care.

Results 1 - 9 of 9

Recs

0
Member Avatar bizcbug7 (72.10) Submitted: 9/20/2013 3:18:59 PM : Outperform Start Price: $37.95 CFN Score: +5.13

Good value metrics, + increasing gross margins and ROA, moderate debt.

Recs

0
Member Avatar rossnr3 (57.21) Submitted: 6/4/2013 10:35:08 AM : Underperform Start Price: $37.47 CFN Score: -2.61

Macroeconomics will suppress growth over next year.

Recs

0
Member Avatar WRXkid (84.93) Submitted: 3/29/2012 2:01:49 PM : Outperform Start Price: $25.82 CFN Score: +35.44

Previous employer, they have premium products that sell for a premium.

Recs

0
Member Avatar XMFConnor (97.73) Submitted: 6/6/2011 5:55:33 PM : Outperform Start Price: $27.64 CFN Score: +13.44

Einhorn/ Spin-off

Recs

0
Member Avatar beachwalker (25.96) Submitted: 5/9/2011 12:00:21 AM : Outperform Start Price: $29.13 CFN Score: +10.10

A sleeper in the med device business. They're the best at at computerizing medicial stores systems for hospitals.

Recs

0
Member Avatar hammyjr (< 20) Submitted: 10/14/2009 10:30:37 AM : Outperform Start Price: $22.65 CFN Score: +19.99

With the government in the insurance business many of the medical stocks will advance.Although the public may get taken over the coals on the premiums and taxes that will be the result of the govt. option.

Recs

1
Member Avatar htownjester (90.39) Submitted: 10/13/2009 2:08:08 AM : Outperform Start Price: $22.97 CFN Score: +15.51

Recent spinoff of CAH. CAH retains 20% of stock and must sell within 5 years- only one reason for them to retain- they think it is offers a very attractive rate of return over that time period. Insider buys and significant insider incentive through RSUs / stock plan for employees. CFN of course also stands to benefit from a very nice pop once the healthcare debate is wrapped up in Washington, and substantively CFN probably has a number of offers which actually can/will reduce the cost of healthcare in this country over the long term.

Recs

0
Member Avatar tuscanstar (66.71) Submitted: 9/22/2009 3:07:00 PM : Outperform Start Price: $21.49 CFN Score: +28.57

Already an industry heavyweight before separation from Cardinal Health. With an already broad market presence, this stock should outperform.

Recs

0
Member Avatar TMFBiologyFool (96.67) Submitted: 9/2/2009 12:38:18 PM : Outperform Start Price: $18.97 CFN Score: +43.22

Hospital spending will bounce back (eventually) and CareFusion should benefit once it does.

Results 1 - 9 of 9

Featured Broker Partners


Advertisement